Abstract
Industry compliance with pharmacoeconomic guidelines means that industry must understand, follow, and anticipate the guidelines. The dilemma of designing international studies which should comply with local guidelines is discussed and the difficulty faced by the industry in coping with this situation covered.
Get full access to this article
View all access options for this article.